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The HOX11 homeobox gene was ﬁrst identiﬁed through studies of the t(7;10) and t(10;14) chromosomal
translocations of acute T-cell leukemia. In addition, analysis of Hox11
2/2 mice has demonstrated a critical role
for this gene in murine spleen development. A possible mode of in vivo function for the HOX11 protein in these
two situations is regulation of target genes following DNA binding via the homeodomain, but little is known
about how HOX11 regulates transcription in vivo. By performing transcriptional studies in yeast and mam-
malian one-hybrid systems, a modular transcriptional transactivation region at the NH2 terminus of HOX11
has been functionally dissected from other parts of the protein. This NH2-terminal region includes the
previously identiﬁed short conserved Hep motif, which itself activates transcription in one-hybrid assays. The
importance of the NH2-terminal region for the function of HOX11 in vivo was assayed by activating a
HOX11-dependent gene in NIH 3T3 cells. Activation of this gene was found to be dependent upon an intact
homeodomain in HOX11, but maximal activation was obtained only when the NH2-terminal 50 amino acids of
HOX11 was present, showing that this region of HOX11 is important for in vivo transcriptional control of a
chromosomal target gene.
Chromosomal translocations in acute leukemias frequently
involve activation of genes encoding proteins involved in tran-
scription (2, 18, 19). The HOX11 homeobox gene was ﬁrst
identiﬁed by cloning the breakpoints of t(7;10)(q35;q24) and
t(10;14)(q24;q11) chromosomal translocations, found in 5 to
10% of patients with acute T-cell leukemia (5, 9, 13, 15). These
translocations result in the HOX11 gene, which is normally
found on chromosome 10, band q24, being placed within the
transcriptional control region of the T-cell receptor d gene on
chromosome 14 or the T-cell receptor d gene on chromosome
7q35 (13, 29). The abnormal expression of HOX11 in T cells as
a result of these chromosomal translocations in humans is
thought to be a key step in the progression toward malignancy
(5, 9, 13, 15), a view reinforced by the demonstration of onco-
genic activity of HOX11 in transplant recipients of MSCV-
HOX11-transduced bone marrow cells (10, 11).
The HOX11 gene belongs to a family of homeodomain-
encoding genes which includes the related Hox11L1 and
Hox11L2 genes ﬁrst characterized in the mouse (4). The ho-
meodomain is conserved within this family, and, like other
homeodomain proteins, the HOX11 family has been impli-
cated in the regulation of cellular growth and differentiation.
In mice, Hox11 is essential for generation of the spleen (3, 21),
promoting survival of the splenic precursor cells (3), and null
mutation of the Hox11L1 gene results in myenteric neuronal
hyperplasia and megacolon (25).
Since the homeodomain is a sequence-speciﬁc DNA-binding
element, most homeodomain-containing proteins are believed
to function through trans regulation (direct or indirect) of
speciﬁc target genes (16). Consistent with this, HOX11 is a
nuclear protein and can bind to DNA in vitro (4, 26) and a
fusion protein consisting of HOX11 fused to the GAL4 DNA-
binding domain (GAL4-DBD) was found to transactivate var-
ious promoters in both yeast and mammalian cells (28). Three
distinct domains of HOX11 were found to be necessary for
transactivation by this fusion protein (28), namely, the glycine-
proline-rich region at the NH2 terminus, the glutamine-rich
region at the COOH terminus, and the homeodomain itself.
However, the only data which pertain to functional character-
istics in non-artiﬁcial reporter assays are that the NH2- and
COOH-terminal regions of HOX11 appear dispensable for
transforming function (11) and that introduction of HOX11
into NIH 3T3 cells results in transcription of a HOX11-depen-
dent gene (denoted Hdg-1 [8]). Therefore, we have assessed
regions of HOX11 required for optimal in vivo transactivation
of the endogenous Hdg-1 gene. In this stringent assay, we show
that deletions in the HOX11 homeodomain (in either the
NH2-terminal arm or the third helix) prevent induction of
Hdg-1 by HOX11. We also show that the NH2-terminal 50-
amino-acid stretch is crucial for optimal function of the
HOX11 protein in vivo.
MATERIALS AND METHODS
Plasmids. The yeast expression vector for the Y1 fusion protein was con-
structed by PCR ampliﬁcation of the HOX11 sequence corresponding to amino
acids 252 to 330 and cloning into NcoI-BamHI-digested pAS-CYH2 (a modiﬁed
version of pAS [6]). This intermediate construct contained a unique KpnI site
preceding the HOX11 sequence, and following digestion with NcoI and KpnI, a
second HOX11 PCR product corresponding to amino acids 1 to 241 was inserted
to create the Y1 expression vector. Y1 protein lacks amino acids 242 to 251 of
HOX11, which are replaced by glycine and threonine residues from the intro-
duced KpnI site. Mutants Y2 to Y11 were made by PCR ampliﬁcation with
primers designed to amplify the indicated regions of HOX11 and the Y1 expres-
sion vector as the template. Y12 to Y17 were constructed by cloning of annealed
oligonucleotides.
Mammalian expression vectors for GAL4-DBD-HOX11 fusions were also
made by PCR ampliﬁcation of the indicated regions of HOX11 and subsequent
cloning in frame into BamHI-XbaI-digested pM1 vector (23). Mammalian ex-
pression vectors for HOX11, HOXDN50, and HOX263C were constructed by
PCR ampliﬁcation of the indicated regions of HOX11 and cloning into the XbaI
site of the pEFBOS vector (17). HOXDN50 also contained a methionine residue
as the ﬁrst amino acid preceding the HOX11 sequence. HOXMHEP and
HOXDHEP were also made by PCR ampliﬁcation of HOX11 sequence with
primers designed to introduce mutations into the Hep motif (indicated in Fig. 3).
pEFBOS-HOXDH3 was made by PCR with the yeast expression vector for Y1 as
the template. pEFBOS-HOXMDPA was made as follows. A HOX11 sequence
corresponding to amino acids 174 to 330 containing the mutated FPWM motif at
amino acids 174 to 177 (changed to MDPA and introducing a unique BamHI
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3502site) was PCR ampliﬁed and cloned into the XbaI site of pEFBOS (clone
pEFBOS-ICMDPA). pEFBOS-ICMDPA contains two XbaI sites; however, the
XbaI site C terminal to the HOX11 sequence can be blocked by dam methyl-
ation, allowing a second HOX11 PCR product corresponding to amino acids 1 to
173 to be cloned into XbaI-BamHI-digested pEFBOS-ICMDPA to create pEF-
BOS-HOXMDPA. The HOXDKN mutation was made by using HOX11 se-
quences inserted at the BamHI-XhoI sites of pBluescript KS. Digestion with
XbaI and BglII removed the sequence corresponding to the ﬁrst 213 codons of
HOX11. This was replaced by a PCR-generated mutant sequence containing an
internal deletion of amino acids 198 to 204. pEFBOS-HOXDKN was made by
PCR with this pBluescript KS-HOXDKN construct as template. The sequences
of all the constructs were veriﬁed.
Yeast transformation and b-galactosidase assay. Yeast strain Hf7c (Clontech)
was grown on yeast extract-peptone-dextrose (YEPD) plates or in supplemented
Sabouraud dextrose (SD) medium and transformed by the lithium acetate
method (22). Yeast cells were assayed for b-galactosidase activity by a modiﬁed
ﬁlter assay (24).
Transient transfections and CAT assays. Cos-7 cells were maintained in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) containing 10% fetal calf serum.
Lipofectin reagent (Gibco-BRL) was used for transient transfections. For each
10-cm tissue culture dish, 5 mg of the reporter plasmid pG5EC and 10 mg of each
pM1-based expression vector were used. A 1-mg portion of pVP65, expressing a
fusion of GAL4-DBD to the VP65 activation domain, was cotransfected with
pG5EC as a positive control. Chloramphenicol acetyltransferase (CAT) assays
were performed 36 h after transfection.
Extract preparation and Western blotting. Yeast extracts were prepared by
sodium dodecyl sulfate extraction (22). Cos-7 and NIH 3T3 cell extracts were
prepared with 300 ml of lysis buffer (10 mM HEPES [pH 7.6], 0.25 M NaCl, 0.5%
Nonidet P-40, 5 mM EDTA) per 10
7 cells. Extracts and molecular weight stan-
dards (prestained protein molecular weight standards, 14,300- to 200,000-molec-
ular-weight range; Gibco-BRL) were electrophoresed through sodium dodecyl
sulfate–15% polyacrylamide gels and transferred to a nitrocellulose membrane
(Schleicher & Schuell). The membranes were blocked for1hi n5 %Marvel
(Premier Beverages) solution and incubated with either a monoclonal GAL4-
DBD antiserum (Santa Cruz Biotechnology) or a polyclonal HOX11 antiserum
(see below). The membranes were incubated with horseradish peroxidase-con-
jugated secondary antibodies prior to visualization of proteins with enhanced
chemiluminescence (ECL) detection reagents (Amersham Life Science).
The HOX11 antiserum was made from bacterially synthesized HOX11 pro-
tein. The HOX11 coding sequence was cloned into the pET-15b bacterial ex-
pression vector (Novagen). Puriﬁed His-tagged HOX11 protein was prepared
and used for rabbit immunization.
Construction of NIH 3T3 clones. NIH 3T3 cells were maintained in DMEM
containing 10% fetal calf serum. The cells were cotransfected with linearized
pEFBOS-based expression plasmid (10 mg) and pMC1neopolyA selection plas-
mid (0.5 mg) with Lipofectin reagent. At 24 h after transfection, selective medium
(DMEM containing 10% fetal calf serum and 0.5 mg of G418 per ml) was added
to the cells. After approximately 12 days in selective medium, G418-resistant
clones were picked and screened by Western blotting for expression of HOX11
protein or by genomic PCR for the presence of integrated pEFBOS vector (data
not shown).
Northern analysis. Northern analysis was carried out as described previously
(20) with 10 mg of total RNA per lane. Probes were labelled by random priming
(7). The Hdg-1 cDNA probe was a 517-bp DpnII fragment of the Hdg-1 cDNA,
and the mouse ATP synthase (subunit c) cDNA was a 246-bp DpnII fragment
(8). Hybridization levels were quantitated with a model 300A computing densi-
tometer (Molecular Dynamics).
RESULTS
The NH2-terminal region of HOX11 activates transcription
in yeast. The ability of GAL4-DBD-HOX11 fusion proteins to
activate the transcription of a reporter gene was tested in yeast
cells. Various HOX11 sequences were fused to GAL4-DBD in
the yeast expression vector pAS-CYH2 (a modiﬁed pAS [6])
and transformed into the Hf7c yeast strain (containing a lacZ
reporter gene with upstream GAL4 DNA-binding sites). Al-
though a fusion of the GAL4-DBD with the complete HOX11
sequence activated the lacZ reporter, the yeast exhibited se-
vere growth problems (data not shown). Thereafter, we used a
basic construct which contains a deletion of the third helix in
the HOX11 homeodomain. This clone resulted in a detectable
fusion protein with no obvious effect on yeast growth and
which was still capable of transcriptional activation (Fig. 1,
Y1).
A series of mutant HOX11 constructs were made, based on
this helix three-deletion mutant as a starting point, for delin-
eation of the activation functions of HOX11 (Fig. 1). Activa-
tion of the reporter gene was observed for constructs Y2, Y3,
Y8, Y9, and Y10. Within these, the minimum region of overlap
which retains the transactivation element is the ﬁrst 50 amino
acids of HOX11. Furthermore, deletion of this 50-residue
stretch (clones Y4 to Y7) destroys the activation activity de-
spite the retention of a segment which can also activate tran-
scription, albeit weakly, when present alone (Y11). The data
therefore indicate that at least two independent regions of the
HOX11 protein can transactivate transcription in this yeast
assay. A previous study identiﬁed three distinct regions of
HOX11 required for optimal transactivation by a GAL4-DBD-
HOX11 fusion (28). These were the glycine-proline-rich region
at the NH2 terminus, the homeodomain, and the glutamine-
rich region at the COOH terminus. The differing results may
reﬂect our deletion of the third helix of the homeodomain.
The ﬁrst 50 amino acids of HOX11 can activate transcrip-
tion in mammalian cells. The ability of the ﬁrst 50 amino acids
FIG. 1. Yeast one-hybrid assay of HOX11 transcriptional activation do-
mains. GAL4-DBD-HOX11 fusions are represented schematically on the left.
The position of the homeodomain is indicated by the dashed vertical lines, and
mutants lacking the third helix of the homeodomain (amino acids 242 to 251) are
marked by the symbol DH3. The ability of each fusion to activate the lacZ
reporter gene, as assessed by the presence of a blue color in the slot blot
b-galactosidase assay, is indicated on the right. Apparent differences in the
intensity of blue coloration are ignored because although expression of the
GAL4-DBD alone and fusions Y1 to Y11 was conﬁrmed by Western blot analysis
with a monoclonal GAL4-DBD antiserum, the levels of protein expression varied
(data not shown).
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was conﬁrmed in mammalian cells. Sequences corresponding
to amino acids 1 to 98 of HOX11 or amino acids 1 to 50 were
fused to the GAL4-DBD in the mammalian expression vector
pM1 (23) (to create pM1-N98 and pM1-N50, respectively [Fig.
2]). These plasmids were transfected into Cos-7 cells together
with the pG5EC reporter construct (23). While the parent
vector pM1 did not activate the reporter gene, transfection of
either pM1-N98 or pM1-N50 resulted in similar levels of acti-
vation of the reporter (Fig. 2A). Therefore, the ﬁrst 50 amino
acids of HOX11 can function independently as a transcrip-
tional transactivation domain in mammalian cells.
The HOX11 Hep sequence can facilitate transcriptional ac-
tivation in both yeast and mammalian cells. Examination of
the amino acid sequence of the HOX11 NH2-terminal region
for motifs which might be important in transcription did not
reveal anything other than the previously noted Hep motif (9).
The Hep sequence is found in several homeodomain proteins
and is related to the octapeptide sequence found in many Pax
proteins (1). An assessment of its role in transactivation by
HOX11 was made by preparing an internal deletion of the Hep
sequence in the expression clone pM1-N50 for transfection of
Cos-7 cells. This analysis (Fig. 2A) showed that the deletion
mutant (pM1-N50DHEP) was signiﬁcantly reduced (10-fold
[Fig. 2C]) in its ability to activate transcription of the cotrans-
fected reporter plasmid. This diminution of function appar-
ently occurs as a direct result of the Hep deletion and is not an
effect of protein expression levels (as judged by CAT activities
normalized to detectable protein levels [Fig. 2B; a quantitation
is given in Fig. 2C]).
The isolated Hep sequence was then tested for the ability to
mediate activation. A construct was made which encoded 15
amino acids encompassing the Hep motif, fused to the GAL4-
DBD. This construct was tested in the yeast one-hybrid assay
system and found to be sufﬁcient for activation (Y12) (Fig. 3,
upper panels), as was the core 8-amino-acid Hep sequence
fused to the GAL4-DBD (Y13) (Fig. 3A, upper panel). The
ability to activate reporter gene transcription was impaired
when the three-core hydrophobic residues were mutated to
glycine (Y14) (Fig. 3A, upper panel) or when two isoleucines
were changed to valines and the leucine was changed to iso-
leucine (Y15) (Fig. 3A, upper panel). These varied activation
effects were not due to reduced protein expression (Fig. 3A,
lower panel).
The Hep sequence has been detected in several homeo-
domain proteins, and the so-called octapeptide sequences of
Pax proteins are related to the Hep sequence (1). Although no
speciﬁc function has been attributed to the Hep segments, our
data on the ability of the HOX11 Hep motif to assist transac-
tivation suggests that protein interactions with this segment
may constitute one of the functions. As a means of testing a
role of related Hep/octapeptide motifs in transcriptional acti-
vation, the Hep motif from the homeodomain protein Hlx and
the octapeptide sequence from Pax-2 were fused to GAL4-
DBD (Y16 and Y17). Figure 3B (upper panel) shows that both
the Hlx and Pax2 sequences behave similarly to the HOX11
Hep motif in activating transcription in yeast at efﬁciencies
comparable to that of the HOX11 Hep motif when protein
levels are compared (Fig. 3B, lower panel).
Maximal activation of the endogenous Hdg-1 gene by
HOX11 in NIH 3T3 cells requires the NH2-terminal 50 amino
acids. The one-hybrid, fusion protein approach used above is
artiﬁcial in both the context of the mutants used (i.e., fusion
with the GAL4-DBD) and the transcription-responsive assay
used (i.e., a transient-reporter assay). A more physiologically
relevant system would be the test of mutagenesis on HOX11
functions in vivo, via activation of a gene known to be regu-
lated by HOX11. Such a gene has recently been identiﬁed
(denoted Hdg-1) by cDNA representational difference analysis
(8). Hdg-1 is upregulated in NIH 3T3 cells stably expressing
HOX11 protein, and this provides an in vivo assay for HOX11
functional domains. NIH 3T3 cells were stably transfected with
expression vectors coding for normal HOX11 proteins or mu-
tant forms. NIH 3T3 clones which expressed mutant HOX11
proteins were isolated (Fig. 4A), and protein expression was
FIG. 2. The NH2-terminal region of HOX11 can activate transcription in
mammalian cells. (A) CAT assay of Cos-7 cells after transfection of GAL4-DBD-
HOX11 fusion plasmids. Cos-7 cells were transfected with the pG5EC reporter
construct alone or in combination with various GAL4-DBD expression vectors:
pM1 (expressing the GAL4-DBD alone), pM1-N98 (expressing amino acids 1 to
98 of HOX11 fused to the GAL4-DBD), pM1-N50 (expressing amino acids 1 to
50 of HOX11 fused to the GAL4-DBD), pM1-N50DHEP (based on pM1-N50
but containing an internal deletion of the Hep motif at amino acids 19 to 26), or
pVP65 (expressing the VP65 activation domain fused to the GAL4-DBD). (B)
Western blot detection of GAL4-DBD-HOX11 fusions in Cos-7 cell extracts.
Extracts were prepared 36 h after transfection and analyzed with a monoclonal
GAL4-DBD antiserum. GAL4-DBD fusion proteins were detected more readily
than was GAL4-DBD, for unknown reasons. (C) Chart showing the relative CAT
activities of pM1-N98, pM1-N50, and pM1-N50DHEP after normalization for
protein expression levels. CAT activity and protein levels were quantitated by
densitometry. The values are expressed as percentages, with pM1-N50 activity
assigned the value of 100%.
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antiserum (Fig. 4B and C, upper panels).
Expression of Hdg-1 was detected as a 2.1-kb transcript in
Northern analysis of RNA from NIH 3T3 clones expressing
wild-type HOX11 but not in NIH 3T3 cells or NIH 3T3 cells
transfected with only the expression vector (Fig. 4B and C,
lower panels). It was found that mutations of the homeo-
domain affected Hdg-1 gene activation. Deletion of the third
helix of the homeodomain prevented Hdg-1 activation
(HOXDH3) (Fig. 4B and C, lower panels, and Fig. 4D), while
deletion of the NH2-terminal arm of the homeodomain (also
required for contacting DNA [16]) resulted in low levels of
Hdg-1 expression (HOXDKN) (Fig. 4B and C, lower panels,
and Fig. 4D). The effects seen with these mutants indicate that
an intact homeodomain is required by HOX11 to induce Hdg-1
expression, most probably therefore acting through DNA bind-
ing (although not necessarily binding to the Hdg-1 gene itself).
In relation to the NH2-terminal region of HOX11, which we
found to be a modular activation domain, a deletion of the
NH2-terminal 50 amino acids of HOX11 (HOXDN50) (Fig.
4A) was found to impair Hdg-1 induction. Although HOX
DN50 and HOX11 protein levels were comparable (Fig. 4B
and C, upper panels), HOXDN50 induced lower levels of
Hdg-1 RNA than did wild-type HOX11 (Fig. 4B and C, lower
panels). Densitometric quantitation of induced RNA levels
show an approximately fourfold reduction of Hdg-1 with
HOXDN50 (Fig. 4D). The NH2-terminal 50 amino acids of
HOX11 therefore appears to be important for the optimal
induction of Hdg-1 in NIH 3T3 cells, and residual levels of
transcription observed after HOXDN50 expression are pre-
sumably mediated by other regions of the HOX11 protein.
The role of the Hep sequence in induction of Hdg-1 expres-
sion was also assessed in NIH 3T3 clones expressing two dif-
ferent Hep mutants (HOXMHEP and HOXDHEP [Fig. 4A]).
FIG. 3. The Hep sequence can function as a sequence-speciﬁc activation domain. (A) The upper panel shows a yeast b-galactosidase slot blot assay of
GAL4-DBD-Hep fusions. Fusions Y10 and Y12 to Y15 are represented schematically. The GAL4-DBD is fused to amino acids 1 to 50 of HOX11 (Y10), amino acids
16 to 30 of HOX11 (Y12), and amino acids 19 to 26 of HOX11 (Y13). Y14 and Y15 are based on Y12 but contain the amino acid substitutions shown. After incubation
of the b-galactosidase assay mixture for 2 h, the ability of each fusion to activate the lacZ reporter gene was assessed by the blue color as indicated (when exposed for
12 h, Y14 and Y15 yielded blue coloration comparable to the 2-h exposure of Y12 and Y13). The lower panel shows Western blot detection of GAL4-DBD-HOX11
fusions in yeast extracts with a monoclonal GAL4-DBD antiserum. (B) The ability to activate in yeast is a conserved function of the Hep/octapeptide motif. The upper
panel shows the results of a yeast b-galactosidase assay of GAL4-DBD-Hep/octapeptide fusions. The fusions Y12, Y16, and Y17 are represented schematically.
GAL4-DBD is fused to a 15-amino-acid peptide encompassing the HOX11 Hep motif (Y12), the Hlx Hep motif (Y16), or the octapeptide sequence from Pax-2 (Y17).
The lower panel shows Western blot detection of GAL4-DBD-Hep/octapeptide fusions in yeast extracts with a monoclonal GAL4-DBD antiserum.
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HOX11 Hep sequence (a mutation which impairs the ability of
the isolated Hep sequence to activate in yeast [Y14] [Fig. 3A]),
and this protein induces Hdg-1 expression at levels 2.5-fold
lower than HOX11 (Fig. 4C, lower panel, and Fig. 4D). How-
ever, the second Hep mutant, HOXDHEP (containing an in-
ternal deletion of the Hep motif) produced clonal differences.
Although HOXDHEP was present (as judged by Western anal-
ysis [Fig. 4C, upper panel]), some NIH 3T3 clones of
HOXDHEP expressed levels of Hdg-1 RNA comparable to
levels induced by wild-type HOX11 (HOXDHEP clones 4 and
5 [Fig. 4C]), while others did not appear to express Hdg-1 at all
(HOXDHEP clones 1, 2, 3, and 6 [Fig. 4C]). No clonal varia-
tion was seen for any other HOX11 protein studied. It is
possible that for HOXDHEP, conditions of growth or speciﬁc
cellular environment will explain this variation, and this is
worthy of a separate investigation. However, the present data
indicate that the Hep sequence plays a role in the transcrip-
tional activation of Hdg-1 mediated by the NH2-terminal re-
gion of HOX11 in vivo.
Cooperative interactions between homeodomain proteins
and Pbx/exd proteins appear to be mediated, at least in part, by
a motif, FPWM, just upstream of the homeodomain (16).
However, mutation of this motif at amino acids 174 to 177
(HOXMDPA [Fig. 4A]) had no effect on the ability to induce
Hdg-1 expression (Fig. 4B, lower panel, and Fig. 4D). There-
fore, if HOX11 does require interaction with a cofactor for
Hdg-1 induction, other regions of the protein must be involved.
In addition, the COOH-terminal region of HOX11, which was
previously thought to contribute to the HOX11 activation po-
tential (28), does not appear to be required for Hdg-1 induc-
tion. A deletion of 67 amino acids from the COOH terminus of
HOX11 (HOX263C [Fig. 4A]) had no effect on Hdg-1 induc-
tion (Fig. 4B, lower panel, and Fig. 4D).
DISCUSSION
NH2-terminal activation domain and the Hep sequence.
HOX11 is assumed to be an important transcriptional regula-
tor, both in the context of genes required for spleen develop-
ment in the embryo and following deregulation of the HOX11
gene by chromosomal translocations, for genes involved in the
development of T-lineage tumors. It is therefore important to
identify regions of HOX11 required for activation of HOX11-
dependent genes in vivo. The results presented here show that
the HOX11 protein can activate endogenous gene expression
(directly or indirectly) in a homeodomain-dependent manner
and that an activation domain at the NH2 terminus of the
protein is important for this.
The NH2-terminal activation domain was initially delineated
by the yeast one-hybrid assay. All fusion proteins containing
the NH2-terminal 50 amino acids of HOX11 activated, includ-
ing a fusion of amino acids 1 to 211 of HOX11 (data not
shown), analogous to the fusion clone used in a two-hybrid
assay (12). This mapping of an activation domain to the NH2-
terminal 50 amino acids of HOX11 differs from the results of
a previous study which identiﬁed multiple regions of HOX11
involved in transactivation, including an NH2-terminal glycine-
proline-rich region of about 190 amino acids (28). In our yeast
one-hybrid analysis, the glycine-proline-rich region does not
appear to be important, with activation function being local-
ized discretely to the NH2-terminal 50 amino acids.
Within the NH2-terminal 50 amino acids of HOX11 is a
conserved Hep sequence for which no function has yet been
assigned. Our data support a possible role for the Hep se-
quence in transcriptional activation. First, it appears to be a
necessary component of the NH2-terminal activation region,
and second, the Hep sequence itself is sufﬁcient to support
activation when used in isolation in one-hybrid assays, with
contributions from conserved hydrophobic residues in the core
sequence. In addition, the Hep motif of Hlx and the related
octapeptide motif of Pax-2 are both capable of activation when
fused to the GAL4-DBD. Previously, the Pax-2 octapeptide
had been shown to act in cis as a transcriptional repressor
domain (14). The Pax-2 octapeptide therefore appears to have
the capacity for modular transcriptional function, being capa-
ble of repression when studied in the context of the Pax-2
protein (14) and activation when studied in isolation. The Hep
sequence may also act in both positive and negative transcrip-
tional regulation.
Regions of HOX11 required for Hdg-1 induction. It has
become apparent that protein activation domains mapped in
reporter assays may not necessarily be important for all in vivo
function; e.g., studies of the GATA-1 transcription factor have
shown that an obligatory activation domain mapped by stan-
dard reporter assays is dispensable for GATA-1 function in
terminal erythroid cell differentiation (27). The relevance of
transcriptional assays which identify protein segments with ac-
tivation potential in isolation from the intact native protein is
therefore at issue. Although the NH2-terminal 50 amino acids
of HOX11 could function as an activation domain in one-
hybrid assays, it was therefore important to evaluate the role of
this region in a functional assay that provides a stringent anal-
ysis of HOX11 protein function. In particular, such an assay
could provide insight into the differing results obtained from
one-hybrid analyses of HOX11 (reference 28 and data pre-
sented above). The gene Hdg-1 is activated after HOX11 ex-
pression in NIH 3T3 cells (8), and this chromosomal activation
provides a powerful physiological model for analysis of
HOX11 functional domains. Whether the induction of Hdg-1
FIG. 4. The NH2-terminal 50 amino acids of HOX11 is required for optimal induction of Hdg-1 expression in NIH 3T3 cells. (A) Schematic representation of
HOX11 wild-type and mutant proteins expressed from the indicated HOX11 constructs made in the pEFBOS vector. The positions of the Hep sequence, the conserved
FPWM motif, and the homeodomain are indicated in the diagram of HOX11, as are the MDPA mutation in HOXMDPA and the mutation of the Hep sequence in
HOXMHEP. The various constructs were cotransfected into NIH 3T3 cells with a neomycin resistance vector, and individual clones were picked. (B) The upper panel
shows Western blot detection of HOX11 wild-type and mutant proteins in extracts from a representative set of NIH 3T3 clones with a polyclonal HOX11 antiserum.
The lower panel shows Northern blot detection of the Hdg-1 transcript in RNA from a representative set of NIH 3T3 clones expressing wild-type and mutant HOX11
proteins. The 2.1-kb Hdg-1 transcript is detected in a clone expressing wild-type HOX11 but not in a clone selected to contain the empty expression vector (pEFBOS)
or in normal NIH 3T3 cells. The effect of various HOX11 mutations (as represented in panel A) on the ability to induce Hdg-1 expression is shown. Although expressed
at a level comparable to that of HOX11, HOXDN50 exhibits a fourfold reduction in its ability to induce Hdg-1 (based on densitometric analysis, as shown in panel D).
Hybridization with an ATP synthase probe was used as a control for loading of the Northern ﬁlter. (C) The upper panel shows Western blot detection of HOX11 Hep
mutants in extracts from NIH 3T3 clones with a polyclonal HOX11 antiserum. Six independent clones expressing HOXDHEP were obtained and analyzed. Three clones
expressing HOXMHEP are shown. The lower panel shows Northern blot detection of the Hdg-1 transcript in RNA from NIH 3T3 clones expressing HOX11 Hep
mutants. The 2.1-kb Hdg-1 transcript is detected in all three HOXMHEP clones but at levels approximately 2.5-fold lower than in HOX11 wild-type clones (based on
densitometric analysis, as shown in panel D). The Hdg-1 transcript is detected in two of the six HOXDHEP clones. Hybridization with an ATP synthase probe was used
as a loading control for the Northern ﬁlter. (D) Histogram showing relative levels of Hdg-1 transcript in NIH 3T3 clones expressing wild-type and mutant HOX11
proteins. In each case, three independent clones were analyzed (except for the HOXDKN mutant, which is based on data obtained with two independent clones). The
relative signal values were obtained by densitometric scanning of autoradiographs and normalized for levels of HOX11 transcript.
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is unknown. Mapping of the Hdg-1 promoter to identify the
“HOX11-responsive element” is in progress to clarify this (8a).
The induction of Hdg-1 expression in transfected NIH 3T3
cells was found to be dependent on the intact homeodomain.
When the NH2-terminal 50 amino acids of HOX11 was de-
leted, Hdg-1 induction was signiﬁcantly impaired (fourfold), in
agreement with mapping of this region as an activation domain
in one-hybrid reporter assays. The NH2-terminal 50 amino
acids of HOX11 is therefore important for in vivo transcrip-
tional control of a chromosomal gene. The Hep sequence,
located within the NH2-terminal 50 amino acids of HOX11,
may play a role in this activation of Hdg-1 transcription. How-
ever, since regions of HOX11 other than the NH2 terminus
contribute to Hdg-1 induction, the in vivo role of the Hep
sequence is difﬁcult to assess. If the Hep sequence is an im-
portant component of the NH2-terminal region, one would
expect Hep mutants to exhibit a reduced level of Hdg-1 induc-
tion comparable to that of the HOXDN50 mutant. Consistent
with this, the HOXMHEP mutant (containing three amino
acid substitutions within the conserved Hep sequence) acti-
vates Hdg-1, with the induced level close to that of HOXDN50
(Fig. 4D).
Although the NH2-terminal 50 amino acids is important for
Hdg-1 induction, other regions of the HOX11 protein are
clearly involved. The homeodomain is essential, since deletions
within this domain (either of the third helix or of the NH2-
terminal arm) result in the loss of Hdg-1 induction. Both these
regions of the homeodomain are predicted to contact DNA,
and so deletions made presumably result in a loss of HOX11
DNA-binding activity. The HOX11 homeodomain has also
been suggested to contain activation function (28) and may
therefore be playing a dual role in Hdg-1 induction. In our
yeast one-hybrid analysis, we were unable to study the intact
HOX11 homeodomain due to growth retardation in the pres-
ence of the functional homeodomain, and it is therefore im-
possible for us to address this question unless speciﬁc muta-
tions which ablate the activation function of the homeodomain
while retaining DNA-binding activity can be identiﬁed. How-
ever, the COOH-terminal glutamine-rich region of HOX11,
which previously had been thought to contain activation func-
tion (28), did not activate in our yeast one-hybrid analysis and
also does not appear to be required for Hdg-1 induction.
Mechanism of Hdg-1 induction. The importance of the NH2-
terminal 50 amino acids of HOX11 for activation of a chro-
mosomal gene in vivo may provide insights into the mecha-
nisms of HOX11-mediated transcriptional regulation by
helping to identify interacting factors. Apart from the con-
served Hep sequence, the NH2-terminal 50 amino acids does
not resemble any known transcriptional regulatory domain.
However, since this region is involved in Hdg-1 induction (but
not necessarily by direct binding to the Hdg-1 promoter), it
presumably interacts, either directly or indirectly, with a com-
ponent(s) of the basal transcriptional machinery. The identiﬁ-
cation of such factors should further delineate the role of the
conserved Hep sequence and help to elucidate the functional
role of HOX11 in both splenogenesis and tumorigenesis.
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